Llwytho...
Ultra‐Rapid Lispro results in accelerated insulin lispro absorption and faster early insulin action in comparison with Humalog(®) in Japanese patients with type 1 diabetes
AIMS/INTRODUCTION: Ultra‐rapid lispro (URLi) is a novel ultra‐rapid mealtime insulin. This study compared the pharmacokinetic and glucodynamic profiles, safety, and tolerability of URLi and lispro (Humalog(®)) in Japanese patients with type 1 diabetes mellitus. MATERIALS AND METHODS: This was a phas...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | J Diabetes Investig |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
John Wiley and Sons Inc.
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7232298/ https://ncbi.nlm.nih.gov/pubmed/31816193 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.13195 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|